Mycoplasma genitalium; pregnant women; azithromycin; macrolide resistance; 23S rRNA gene mutations; KwaZulu-Natal.

Mycoplasma genitalium; pregnant women; azithromycin; macrolide resistance; 23S rRNA gene mutations; KwaZulu-Natal.

Background: Azithromycin regimens have been considered first-line treatment for Mycoplasma genitalium (M. genitalium), a sexually transmitted infection (STI) associated with adverse pregnancy outcomes. However, recent years have seen rapid emergence of macrolide resistance in M. genitalium as a resu...

Full description

Bibliographic Details
Main Authors: Meleshni Naicker, Ravesh Singh, Donald van der Westhuizen, Partson Tinarwo, Nathlee S. Abbai
Format: Article
Language:English
Published: AOSIS 2021-01-01
Series:Southern African Journal of Infectious Diseases
Subjects:
mycoplasma genitalium
pregnant women
azithromycin
macrolide resistance
23s rrna gene mutations
kwazulu-natal
Online Access:https://sajid.co.za/index.php/sajid/article/view/209

Similar Items

Similar Items